v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenue $ 704,000 $ 1,052,000 $ 2,008,000 $ 4,064,000
Cost of revenue 1,071,000 941,000 2,200,000 2,882,000
Gross profit (loss) (367,000) 111,000 (192,000) 1,182,000
Operating expenses:        
Research and development 1,224,000 2,902,000 2,862,000 5,382,000
Selling, general and administrative 3,350,000 5,530,000 7,715,000 12,156,000
Restructuring costs 742,000
Total operating expenses 4,574,000 8,432,000 10,577,000 18,280,000
Loss from operations (4,941,000) (8,321,000) (10,769,000) (17,098,000)
Modification of Series A and B warrants (1,838,000) (1,838,000)
Interest expense, net (223,000) (1,194,000) (433,000) (2,310,000)
Other expense, net (27,000) (71,000) (117,000) (82,000)
Net loss from consolidated companies (7,029,000) (9,586,000) (13,157,000) (19,490,000)
Loss from minority interest in limited liability company (86,000) (138,000) (268,000) (263,000)
Comprehensive and net loss (7,115,000) (9,724,000) (13,425,000) (19,753,000)
Series B convertible preferred stock dividends (1,021,000) (2,011,000)
Net loss attributable to common stockholders $ (8,136,000) $ (9,724,000) $ (15,436,000) $ (19,753,000)
Net loss per share of common stock:        
Basic and diluted (in dollars per share) $ (0.57) $ (20.93) $ (1.34) $ (42.54)
Weighted average shares used in computing net loss per common share:        
Basic and diluted (in shares) 14,186,199 464,638 11,558,472 464,321

Source